Paradigm Biopharmaceuticals Ltd
ASX:PAR
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Price:
0.295
AUD
Market Closed
Market Cap:
AU$127.9m
Balance Sheet
Balance Sheet Decomposition
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Balance Sheet
Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd
Currency: AUD
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
3
|
2
|
72
|
104
|
71
|
40
|
56
|
18
|
17
|
|
| Cash |
0
|
0
|
3
|
3
|
2
|
72
|
104
|
71
|
40
|
56
|
18
|
17
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
7
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
2
|
3
|
4
|
4
|
9
|
7
|
8
|
6
|
6
|
|
| Accounts Receivables |
0
|
0
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
0
|
1
|
4
|
4
|
5
|
83
|
108
|
81
|
47
|
65
|
25
|
24
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
8
|
10
|
10
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+443%
|
12
+934%
|
14
+16%
|
15
+6%
|
86
+463%
|
112
+31%
|
85
-25%
|
51
-40%
|
68
+34%
|
28
-58%
|
25
-13%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
1
|
2
|
3
|
5
|
7
|
12
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
1
|
3
|
3
|
6
|
8
|
13
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+58%
|
1
+91%
|
1
-14%
|
1
+39%
|
3
+104%
|
4
+55%
|
7
+56%
|
8
+28%
|
13
+60%
|
4
-73%
|
3
-5%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
2
|
15
|
21
|
27
|
109
|
146
|
147
|
147
|
210
|
238
|
253
|
|
| Retained Earnings |
0
|
1
|
4
|
8
|
13
|
27
|
38
|
69
|
105
|
155
|
212
|
231
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
0
N/A
|
1
N/A
|
11
+1 744%
|
13
+19%
|
14
+4%
|
83
+497%
|
108
+31%
|
78
-28%
|
42
-46%
|
55
+29%
|
25
-55%
|
21
-15%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+443%
|
12
+934%
|
14
+16%
|
15
+6%
|
86
+463%
|
112
+31%
|
85
-25%
|
51
-40%
|
68
+34%
|
28
-58%
|
25
-13%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
48
|
48
|
90
|
105
|
128
|
194
|
226
|
238
|
241
|
290
|
350
|
389
|
|
Switch to:
Switch to:
See Also
Discover More
